Phase I study of intratumoral application of recombinant human tumor necrosis factor

European Journal of Cancer and Clinical Oncology

Volumn 25, Issue 2, 1989, Pages

  Pfreundschuh, Michael G ^a   Tilman Steinmetz, H ^a   Tüschen, Rolf ^a   Schenk, Volker ^a   Diehl, Volker ^a   Schaadt, Michael ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; CHILL; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; MALE; PHASE 1 CLINICAL TRIAL; SOLID TUMOR; TACHYCARDIA;

ADOLESCENT; ADULT; AGED; DRUG EVALUATION; FEMALE; HUMAN; INJECTIONS; MALE; MIDDLE AGE; NEOPLASMS; TIME FACTORS; TUMOR NECROSIS FACTOR;

EID: 0024555477     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(89)90034-5     Document Type: Article

References (19)

1. An endotoxin-induced serum factor that causes necroses of tumors
2. Tumor necrosis factor (TNF)
3. Identity of tumour necrosis factor and the macrophage-secreted factor cachetin
4. Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line
5. Human tumor necrosis factor
6. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted tumors in nude mice
7. Human necrosis factor: precursor structure, expression and homology to lymphotoxin
8. Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor
9. Molecular cloning of the complementary DNA for tumor necrosis factor
10. Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor
11. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1
12. The adoptive immunotherapy of cancer using the transfer of activated lymphoid cells and interleukin-2
13. Inhibition of the growth and differentiation of erythroid precursor cells by an endotoxin-induced mediator from peritoneal macrophages
14. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-γ
15. Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte macrophage colony-stimulating factor
16. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells
17. Phase I study of recombinant tumor necrosis factor in cancer patients
18. Changes in immune function in patients receiving natural leukocyte interferon
19. Phase I study of 24-hour continuous infusion of recombinant human tumor necrosis factor